Filing Details
Turn Therapeutics Inc. (NASDAQ:TTRX) filed a Form 8-K with the Securities and Exchange Commission on July 07, 2026, disclosing a material event.
8k filedNASDAQ:TTRX
Turn Therapeutics Inc. (TTRX) Reports Material Event to SEC
Filing Details Turn Therapeutics Inc. (NASDAQ:TTRX) filed a Form 8-K with the Securities and Exchange Commission on July 07, 2026, disclosing a material event. Market Context Turn…
Market Context
Turn Therapeutics Inc.'s stock currently trades at $9.71 with a market capitalization of $96.1M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Turn Therapeutics Inc.'s stock.
All SEC filings for Turn Therapeutics Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View TTRX Stock Page
Frequently Asked Questions
Where can I read TTRX's SEC filings?
Browse all filings on our TTRX SEC filings page.
What types of SEC filings does Turn Therapeutics Inc. file?
Public companies like Turn Therapeutics Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.